Treatment of recurrent stage IV neuroblastomas with 131I-MIBG and HBO Six years follow-up.
van der Kleij
A J
AJ
Dept of Surgery, University of Amsterdam, The Netherlands.
Voûte
P A
PA
D019797:3-Iodobenzylguanidine; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002648:Child; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006931:Hyperbaric Oxygenation; D007462:Iodobenzenes / Q000627:therapeutic use*; D008297:Male; D009364:Neoplasm Recurrence, Local; D009447:Neuroblastoma / Q000188:drug therapy / Q000401:mortality / Q000628:therapy*; D015996:Survival Rate; D013997:Time Factors
D000970:Antineoplastic Agents; D007462:Iodobenzenes; D019797:3-Iodobenzylguanidine